Cargando…
Extensive reprogramming of the nascent transcriptome during iPSC to hepatocyte differentiation
Hepatocyte-like cells (HLCs) derived from induced pluripotent stem cells (iPSCs) provide a renewable source of cells for drug discovery, disease modelling and cell-based therapies. Here, by using GRO-Seq we provide the first genome-wide analysis of the nascent RNAs in iPSCs, HLCs and primary hepatoc...
Autores principales: | Viiri, Leena E., Rantapero, Tommi, Kiamehr, Mostafa, Alexanova, Anna, Oittinen, Mikko, Viiri, Keijo, Niskanen, Henri, Nykter, Matti, Kaikkonen, Minna U., Aalto-Setälä, Katriina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401154/ https://www.ncbi.nlm.nih.gov/pubmed/30837492 http://dx.doi.org/10.1038/s41598-019-39215-0 |
Ejemplares similares
-
Coronary artery disease patient-derived iPSC-hepatocytes have distinct miRNA profile that may alter lipid metabolism
por: Alexanova, Anna, et al.
Publicado: (2023) -
Lipidomic profiling of patient-specific iPSC-derived hepatocyte-like cells
por: Kiamehr, Mostafa, et al.
Publicado: (2017) -
A Comparative View on Easy to Deploy non-Integrating Methods for Patient-Specific iPSC Production
por: Manzini, Stefano, et al.
Publicado: (2015) -
Improvements in Maturity and Stability of 3D iPSC-Derived Hepatocyte-like Cell Cultures
por: Suominen, Siiri, et al.
Publicado: (2023) -
Analysis of Drug Effects on iPSC Cardiomyocytes with Machine Learning
por: Juhola, Martti, et al.
Publicado: (2020)